The magnitude of disability in patients with schizophrenia in North West Ethiopia: A multicenter hospital-based cross-sectional study.
Disability
Mental health
Schizophrenia
Journal
Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
received:
24
12
2020
revised:
02
04
2021
accepted:
07
05
2021
entrez:
27
5
2021
pubmed:
28
5
2021
medline:
28
5
2021
Statut:
epublish
Résumé
To assess the magnitude of disability and its associated factors among patients with schizophrenia in North West Ethiopia in selected hospitals, 2019. Multicenter hospital-based cross-sectional study. Gondar, Felege Hiwot, and Debre Tabor hospitals. We recruit 420 participants for interviews using a systematic random sampling technique. We collect the data by face-to-face interview. Disability was measured using the World Health Organization Disability Assessment Scale 2.0. Coded variables were entered into Epi data V.4.4.2 and exported to SPSS V.24 for analysis. Bivariate and multivariate logistic regressions with OR and 95% CI were employed. A total of 423 participants were interviewed, with a response rate of 99.3%. The magnitude of disability in this study was 41.7 % (95 %CI: 36.9, 46.4). Current use of alcohol (AOR = 2.47,n95CI; 1.36,4.48), being jobless (AOR = 3.27, 95CI; 1.80, 5.93), had negative symptoms (AOR = 13.05,95CI, 7.58,22.45), had 5 and more years of illness (AOR = 2.75,95CI; 1.29,5.86), and had 5 and more years of untreated psychosis (AOR = 3.78,95CI, 1.85,7.75) were predictors of disability. The magnitude of disability in this study was 41.7 %. Avoidance of alcohol usage, early initiation of treatment, creating job opportunities, and giving special emphasis to patients having negative symptoms is recommended.
Identifiants
pubmed: 34041398
doi: 10.1016/j.heliyon.2021.e07053
pii: S2405-8440(21)01156-7
pmc: PMC8141773
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e07053Informations de copyright
© 2021 Published by Elsevier Ltd.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Schizophr Res. 2012 Jul;138(2-3):240-7
pubmed: 22521724
Neuropsychiatr Dis Treat. 2020 Feb 21;16:519-534
pubmed: 32110026
Psychiatry Res. 2014 Dec 15;220(1-2):181-7
pubmed: 25113924
Recent Dev Alcohol. 1998;14:285-99
pubmed: 9751950
Int J Soc Psychiatry. 2020 Mar;66(2):179-187
pubmed: 31885321
Psychol Med. 2001 Apr;31(3):381-400
pubmed: 11305847
Soc Psychiatry Psychiatr Epidemiol. 1997 Oct;32(7):387-90
pubmed: 9383969
Psychiatry Res. 2005 Jun 15;135(2):103-11
pubmed: 15923043
Eur Child Adolesc Psychiatry. 2015 Dec;24(12):1447-59
pubmed: 25726022
Ind Psychiatry J. 2012 Jul;21(2):173-7
pubmed: 24250056
Bull World Health Organ. 2001;79(11):1047-55
pubmed: 11731812
Eur Arch Psychiatry Clin Neurosci. 2018 Feb;268(1):65-75
pubmed: 28801847
Schizophr Res. 2006 Oct;87(1-3):246-53
pubmed: 16859898
Schizophr Bull. 2007 Sep;33(5):1225-37
pubmed: 17204532
Addiction. 2008 Jun;103(6):1039-47
pubmed: 18373724
Am J Psychiatry. 2005 Oct;162(10):1785-804
pubmed: 16199825
Indian J Med Res. 2005 Jun;121(6):759-63
pubmed: 16037620
Indian J Psychiatry. 2010 Jan;52(1):37-41
pubmed: 20174516
Health Qual Life Outcomes. 2017 Apr 5;15(1):64
pubmed: 28381230
Psychiatr Serv. 2015 Mar 1;66(3):249-57
pubmed: 25727112